PMA device
Durasphere Injectable Bulking Agent
Carbon Medical Technologies, Inc. · Agent, Bulking, Injectable For Gastro-Urology Use (LNM, Class III) · First FDA decision Apr 2, 2001, newest Mar 13, 2026Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
1
Naming "Durasphere"
MAUDE reports
1
Brand "Durasphere", since 2015
PubMed studies
38
Mentioning "Durasphere"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Durasphere Injectable Bulking Agent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- Durasphere Injectable Bulking AgentPMA supplement
P980053-S021 · Decided Mar 13, 2026 · 414 days after receipt · Normal 180 Day Track
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
- Durasphere Injectable Bulking AgentPMA supplement
P980053-S018 · Decided Feb 25, 2021 · 59 days after receipt · Normal 180 Day Track No User Fee
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
- DURASPHERE INJECTABLE BULKING AGENTPMA supplement
P980053-S009 · Decided May 25, 2005 · 139 days after receipt · Normal 180 Day Track No User Fee
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P980053-S003
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Durasphere", any status and sponsor, newest update first.
Carbon Medical TechnologiesNot on our public-company list
NCT00762047 · 90 participants · Start Jun 2004 · Primary completion Aug 2008
Device: Durasphere FI; Sham · For: Fecal Incontinence
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Durasphere", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code LNM
544 reports: 170 malfunction, 369 injury, 2 death
Newest reports for this brand
CARBON MEDICAL TECHNOLOGIES, INC.
2134494-2017-00002 · Received Jan 31, 2018 · Event dated Nov 21, 2017
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Abscess
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Durasphere"[tiab]. The summary above synthesizes these.
- Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence.
Madjar S, Sharma AK, Waltzer WC, et al. · J Urol · 2006
- Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence.
Andersen RC · J Low Genit Tract Dis · 2002
- Endoscopic evacuation of Durasphere.
Hartanto VH, Lightner DJ, Nitti VW · Urology · 2003Case Reports
- Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review.
Hoe V, Haller B, Yao HH, et al. · Neurourol Urodyn · 2021Systematic Review
- Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup.
Chrouser KL, Fick F, Goel A, et al. · J Urol · 2004Comparative Study
- Urethral prolapse after durasphere injection.
Ghoniem GM, Khater U · Int Urogynecol J Pelvic Floor Dysfunct · 2006Case Reports
- Update on Urethral Bulking for Stress Urinary Incontinence in Women.
Zheng Y, Rovner E · Curr Urol Rep · 2022Review
- Urethral bulking agents: imaging review.
Bridges MD, Petrou SP, Lightner DJ · AJR Am J Roentgenol · 2005
- A pilot study of ultrasound guided Durasphere injection in the treatment of faecal incontinence.
Beggs AD, Irukulla S, Sultan AH, et al. · Colorectal Dis · 2010
- Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence.
Altomare DF, La Torre F, Rinaldi M, et al. · Dis Colon Rectum · 2008Comparative Study, Research Support, Non-U.S. Gov't
- Urethral bulking agents for female stress urinary incontinence.
Hussain SM, Bray R · Neurourol Urodyn · 2019Review
- Comparison of bulking agents in the treatment of fecal incontinence: a prospective randomized clinical trial.
Morris OJ, Smith S, Draganic B · Tech Coloproctol · 2013Comparative Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code LNM.
- Deflux Injectable GelPalette Life Sciences · PMA 2016
- Macroplastique ImplantsUroplasty, LLC · PMA 2023
- Solesta (Injectable Gel)Palette Life Sciences · PMA 2021
- Coaptite Injectable ImplantMerz North America, Inc. · PMA 2024
- Contigen Bard Collagen ImplantAllergan, Inc. · PMA 2009
- Bard Tegress Urethral ImplantC.R. Bard, Inc. · PMA 2006
- Enteryx Procedure KitBoston Scientific Corp · PMA 2005
- Durasphere ExpCarbon Medical Technologies, Inc. · PMA 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.